Mednax Inc (MD) - Net Assets
Based on the latest financial reports, Mednax Inc (MD) has net assets worth $890.67 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($2.20 Billion) and total liabilities ($1.31 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MD financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $890.67 Million |
| % of Total Assets | 40.5% |
| Annual Growth Rate | 13.73% |
| 5-Year Change | 2.3% |
| 10-Year Change | -68.62% |
| Growth Volatility | 58.58 |
Mednax Inc - Net Assets Trend (1994–2024)
This chart illustrates how Mednax Inc's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Mednax Inc for the complete picture of this company's asset base.
Annual Net Assets for Mednax Inc (1994–2024)
The table below shows the annual net assets of Mednax Inc from 1994 to 2024. For live valuation and market cap data, see market cap of Mednax Inc.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $764.94 Million | -9.91% |
| 2023-12-31 | $849.06 Million | -4.77% |
| 2022-12-31 | $891.63 Million | -0.56% |
| 2021-12-31 | $896.69 Million | +19.92% |
| 2020-12-31 | $747.72 Million | -50.12% |
| 2019-12-31 | $1.50 Billion | -51.46% |
| 2018-12-31 | $3.09 Billion | +0.70% |
| 2017-12-31 | $3.07 Billion | +11.07% |
| 2016-12-31 | $2.76 Billion | +13.25% |
| 2015-12-31 | $2.44 Billion | +7.60% |
| 2014-12-31 | $2.27 Billion | -3.30% |
| 2013-12-31 | $2.34 Billion | +15.11% |
| 2012-12-31 | $2.04 Billion | +17.58% |
| 2011-12-31 | $1.73 Billion | +19.59% |
| 2010-12-31 | $1.45 Billion | +21.62% |
| 2009-12-31 | $1.19 Billion | +23.31% |
| 2008-12-31 | $965.14 Million | +0.63% |
| 2007-12-31 | $959.05 Million | +10.77% |
| 2006-12-31 | $865.80 Million | +25.15% |
| 2005-12-31 | $691.79 Million | +21.15% |
| 2004-12-31 | $571.03 Million | -0.24% |
| 2003-12-31 | $572.38 Million | +4.45% |
| 2002-12-31 | $548.00 Million | +14.44% |
| 2001-12-31 | $478.85 Million | +97.95% |
| 2000-12-31 | $241.90 Million | +5.68% |
| 1999-12-31 | $228.90 Million | +10.37% |
| 1998-12-31 | $207.40 Million | +26.70% |
| 1997-12-31 | $163.70 Million | +20.10% |
| 1996-12-31 | $136.30 Million | +117.04% |
| 1995-12-31 | $62.80 Million | +290.06% |
| 1994-12-31 | $16.10 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mednax Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 82946.7% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $859.00K | 0.11% |
| Other Comprehensive Income | $-1.07 Million | -0.14% |
| Other Components | $1.01 Billion | 132.52% |
| Total Equity | $764.94 Million | 100.00% |
Mednax Inc Competitors by Market Cap
The table below lists competitors of Mednax Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nantong Jiangshan Agrochemical & Chemicals Co Ltd
SHG:600389
|
$1.82 Billion |
|
Sirius Real Estate Ltd
JSE:SRE
|
$1.82 Billion |
|
Mesoblast Ltd
NASDAQ:MESO
|
$1.82 Billion |
|
Stoke Therapeutics Inc
NASDAQ:STOK
|
$1.82 Billion |
|
Pharvaris BV
NASDAQ:PHVS
|
$1.82 Billion |
|
TianJin 712 Communication & Broadcasting Co Ltd
SHG:603712
|
$1.82 Billion |
|
John Wiley & Sons
NYSE:WLY
|
$1.82 Billion |
|
DANAOS CORP. DL -01
F:DVW1
|
$1.82 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mednax Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 849,061,000 to 764,938,000, a change of -84,123,000 (-9.9%).
- Net loss of 99,069,000 reduced equity.
- Share repurchases of 1,703,000 reduced equity.
- New share issuances of 3,638,000 increased equity.
- Other comprehensive income increased equity by 1,143,000.
- Other factors increased equity by 11,868,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-99.07 Million | -12.95% |
| Share Repurchases | $1.70 Million | -0.22% |
| Share Issuances | $3.64 Million | +0.48% |
| Other Comprehensive Income | $1.14 Million | +0.15% |
| Other Changes | $11.87 Million | +1.55% |
| Total Change | $- | -9.91% |
Book Value vs Market Value Analysis
This analysis compares Mednax Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.48x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 73.54x to 2.48x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1994-12-31 | $0.31 | $22.75 | x |
| 1995-12-31 | $1.20 | $22.75 | x |
| 1996-12-31 | $1.17 | $22.75 | x |
| 1997-12-31 | $1.35 | $22.75 | x |
| 1998-12-31 | $3.14 | $22.75 | x |
| 1999-12-31 | $3.61 | $22.75 | x |
| 2000-12-31 | $3.77 | $22.75 | x |
| 2001-12-31 | $5.33 | $22.75 | x |
| 2002-12-31 | $5.14 | $22.75 | x |
| 2003-12-31 | $5.82 | $22.75 | x |
| 2004-12-31 | $6.19 | $22.75 | x |
| 2005-12-31 | $7.18 | $22.75 | x |
| 2006-12-31 | $8.77 | $22.75 | x |
| 2007-12-31 | $9.61 | $22.75 | x |
| 2008-12-31 | $10.23 | $22.75 | x |
| 2009-12-31 | $12.80 | $22.75 | x |
| 2010-12-31 | $15.21 | $22.75 | x |
| 2011-12-31 | $17.69 | $22.75 | x |
| 2012-12-31 | $20.35 | $22.75 | x |
| 2013-12-31 | $23.15 | $22.75 | x |
| 2014-12-31 | $22.68 | $22.75 | x |
| 2015-12-31 | $25.95 | $22.75 | x |
| 2016-12-31 | $29.46 | $22.75 | x |
| 2017-12-31 | $32.72 | $22.75 | x |
| 2018-12-31 | $33.71 | $22.75 | x |
| 2019-12-31 | $17.79 | $22.75 | x |
| 2020-12-31 | $8.73 | $22.75 | x |
| 2021-12-31 | $10.37 | $22.75 | x |
| 2022-12-31 | $10.60 | $22.75 | x |
| 2023-12-31 | $10.33 | $22.75 | x |
| 2024-12-31 | $9.18 | $22.75 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Mednax Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -12.95%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -4.92%
- • Asset Turnover: 0.94x
- • Equity Multiplier: 2.81x
- Recent ROE (-12.95%) is below the historical average (4.08%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1994 | 33.54% | 16.46% | 1.62x | 1.26x | $3.79 Million |
| 1995 | 10.67% | 15.26% | 0.63x | 1.11x | $420.00K |
| 1996 | 9.61% | 16.21% | 0.51x | 1.17x | $-530.00K |
| 1997 | 12.77% | 16.21% | 0.65x | 1.20x | $4.53 Million |
| 1998 | 14.47% | 15.70% | 0.68x | 1.35x | $8.99 Million |
| 1999 | 10.92% | 11.01% | 0.68x | 1.46x | $2.11 Million |
| 2000 | 4.54% | 4.52% | 0.75x | 1.34x | $-13.20 Million |
| 2001 | 6.35% | 8.58% | 0.62x | 1.20x | $-17.46 Million |
| 2002 | 12.55% | 14.78% | 0.72x | 1.18x | $13.98 Million |
| 2003 | 14.73% | 15.30% | 0.77x | 1.25x | $27.09 Million |
| 2004 | 17.21% | 15.86% | 0.79x | 1.38x | $41.18 Million |
| 2005 | 12.87% | 12.84% | 0.77x | 1.30x | $19.86 Million |
| 2006 | 14.38% | 15.21% | 0.72x | 1.31x | $37.88 Million |
| 2007 | 14.88% | 15.55% | 0.70x | 1.36x | $46.82 Million |
| 2008 | 17.53% | 15.84% | 0.71x | 1.55x | $72.69 Million |
| 2009 | 14.77% | 13.65% | 0.76x | 1.42x | $56.79 Million |
| 2010 | 14.00% | 14.46% | 0.69x | 1.41x | $57.95 Million |
| 2011 | 12.59% | 13.73% | 0.70x | 1.31x | $44.90 Million |
| 2012 | 11.84% | 13.26% | 0.66x | 1.35x | $37.37 Million |
| 2013 | 11.97% | 13.02% | 0.71x | 1.30x | $46.22 Million |
| 2014 | 14.00% | 13.01% | 0.68x | 1.59x | $90.72 Million |
| 2015 | 13.80% | 12.10% | 0.61x | 1.87x | $92.54 Million |
| 2016 | 11.77% | 10.21% | 0.60x | 1.93x | $48.84 Million |
| 2017 | 10.45% | 9.26% | 0.59x | 1.91x | $13.73 Million |
| 2018 | 8.70% | 7.37% | 0.61x | 1.92x | $-40.16 Million |
| 2019 | -99.91% | -84.15% | 0.43x | 2.77x | $-1.65 Billion |
| 2020 | -106.56% | -45.93% | 0.52x | 4.48x | $-871.24 Million |
| 2021 | 14.61% | 6.85% | 0.70x | 3.04x | $41.32 Million |
| 2022 | 7.44% | 3.36% | 0.84x | 2.63x | $-22.83 Million |
| 2023 | -7.11% | -3.03% | 0.90x | 2.61x | $-145.31 Million |
| 2024 | -12.95% | -4.92% | 0.94x | 2.81x | $-175.56 Million |
Industry Comparison
This section compares Mednax Inc's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $483,971,162
- Average return on equity (ROE) among peers: 2.24%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mednax Inc (MD) | $890.67 Million | 33.54% | 1.47x | $1.82 Billion |
| Acadia Healthcare Company Inc (ACHC) | $3.19 Billion | 8.01% | 0.87x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $127.96 Million | 9.57% | 0.41x | $1.84 Billion |
| agilon health Inc (AGL) | $-232.03 Million | 0.00% | 0.00x | $264.44 Million |
| Airsculpt Technologies Inc (AIRS) | $83.99 Million | -5.33% | 1.43x | $136.11 Million |
| Amedisys Inc (AMED) | $447.82 Million | 14.54% | 0.31x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $449.38 Million | 23.55% | 1.64x | $624.22 Million |
| American Shared Hospital Service (AMS) | $-10.40 Million | 0.00% | 0.00x | $11.17 Million |
| American Oncology Network Inc. (AONC) | $70.71 Million | -7.84% | 4.30x | $270.55 Million |
| Ardent Health Partners, Inc. (ARDT) | $711.84 Million | -20.09% | 2.86x | $1.29 Billion |
| Astrana Health Inc (ASTH) | $-391.38K | 0.00% | 0.00x | $1.57 Billion |
About Mednax Inc
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric … Read more